Since NF1 deficient tumor cells are generally characterized by over-activation of Ras and, as we demonstrated, by CRABP2 expression, the combination of MEKi and ATRA seems to be a promising new approach, necessarily to be validated in animal experiments. This evidence concerns the gene CRABP2 and neoplasm.